Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Synaptic transmission pathways refer to the complex series of molecular and cellular events that enable the transfer of information between neurons at synapses, primarily through the release of neurotransmitters from a presynaptic neuron, which cross the synaptic cleft and act upon receptors on the postsynaptic cell to elicit a biological response[1][3][7][9]. These pathways underlie critical brain functions including perception, movement, cognition, learning, and memory, and disruptions are implicated in many neurological and psychiatric disorders[2][7][9]. They involve a large number of targetable molecular components—such as neurotransmitter receptors (e.g., glutamate and GABA receptors), ion channels, transporters, enzymes involved in neurotransmitter synthesis and degradation, and synaptic vesicle proteins—which can individually serve as therapeutic targets, but the pathway as a whole is not itself a discrete target[1][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synaptic transmission pathways.